Focus: Galvanize Therapeutics is a public biotech company specializing in bronchoscopic delivery of non-thermal pulsed electric fields (PEF) for oncology indications, particularly lung cancer. The company operates at scale with 5,000+ employees and is advancing its Aliya platform across multiple tumor types.
Profile data last refreshed 4h ago · AI intelligence enriched 1mo ago
Stable — net +4 jobs in 30d
6 added, 2 removed. Backfill posture.
A recently FDA-validated device company with scale and public stability, but limited immediate hiring and an early-stage pipeline create uncertainty about career growth velocity and job availability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Galvanize Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Galvanize Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Galvanize Therapeutics finds signs Aliya PEF may activate immune response in lung cancer - Mugglehead Investment Magazine
Galvanize Therapeutics finds signs Aliya PEF may activate immune response in lung cancer Mugglehead Investment Magazine
Galvanize Therapeutics® Announces the Latest Exploratory Evidence Suggesting Immune-Activating Potential of Aliya® PEF Energy - PR Newswire
Galvanize Therapeutics® Announces the Latest Exploratory Evidence Suggesting Immune-Activating Potential of Aliya® PEF Energy PR Newswire
Galvanize Therapeutics® Announces the Latest Exploratory Evidence Suggesting Immune-Activating Potential of Aliya® PEF Energy - Eastern Progress
Galvanize Therapeutics® Announces the Latest Exploratory Evidence Suggesting Immune-Activating Potential of Aliya® PEF Energy Eastern Progress
Galvanize Therapeutics® Announces First Commercial Procedures Using the New Aliya® EX System - PR Newswire
Galvanize Therapeutics® Announces First Commercial Procedures Using the New Aliya® EX System PR Newswire
Galvanize Therapeutics Receives FDA Clearance for Aliya EX Generator, Expanding its Aliya Pulsed Electric Field Portfolio for Surgical Ablation of Soft Tissue - PR Newswire
Galvanize Therapeutics Receives FDA Clearance for Aliya EX Generator, Expanding its Aliya Pulsed Electric Field Portfolio for Surgical Ablation of Soft Tissue PR Newswire
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Pulsed Electric Field Ablation Reprograms Tumor Immunity and Stimulates Germinal Center Formation in Tertiary Lymphoid Structures in Patients with Non-Small Cell Lung Cancer.
Airway Mucus Plugging in Chronic Bronchitis and the Impact of Bronchial Rheoplasty.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo